Home
About
About AMPEL
Executive Team
Advisory Group
Events
Platform
Products
Partnerships
Papers
Platform
Products
Lupus
Dermatology
Nephrology
Fibromyalgia
Cardiology
Arthritis
Infections
Medical Affairs
Partners
All Papers
News
All News
Company
Platform
Products
Lupus
Dermatology
Nephrology
Cardiology
Fibromyalgia
Infections
Partners
Contact
Contact Us
AMPEL BioSolutions’ Machine Learning Breakthrough Predicts Chronic Disease Flares from a Blood Sample
Sep 14, 2021
|
Lupus
,
Lupus 2022
,
News
,
Products
Search for:
Recent Posts
Virginia Workforce Award to AMPEL BioSolutions
Charlottesville-area company receives praise for internship program
Innovator-of-Year to AMPEL
Innovators, Educators, and Entrepreneurs Recognized at North Fork
From Genomic Tests to AI Predictions: Dr. Amrie Grammer, Co-Founder of AMPEL BioSolutions, Joins BioTalk
Virginia Catalyst Awards $2 Million in Grants to Support Life Sciences in the Commonwealth
Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee
AMPEL BioSolutions Developing Molecular Test to Predict Kidney Damage in Lupus Nephritis Patients
Virginia Workforce Award to AMPEL BioSolutions
LEARN MORE
X
Pin It on Pinterest